APA (7th ed.) Citation

KA, M., ML, B., TE, S., MA, Y., MHN, T., J, K., . . . G, M. (2017). Psychosocial morbidity in TP53 mutation carriers: Is whole-body cancer screening beneficial? Familial cancer, 16(3), 423. https://doi.org/10.1007/s10689-016-9964-7

Chicago Style (17th ed.) Citation

KA, McBride, et al. "Psychosocial Morbidity in TP53 Mutation Carriers: Is Whole-body Cancer Screening Beneficial?" Familial Cancer 16, no. 3 (2017): 423. https://doi.org/10.1007/s10689-016-9964-7.

MLA (9th ed.) Citation

KA, McBride, et al. "Psychosocial Morbidity in TP53 Mutation Carriers: Is Whole-body Cancer Screening Beneficial?" Familial Cancer, vol. 16, no. 3, 2017, p. 423, https://doi.org/10.1007/s10689-016-9964-7.